Summary of HOLLIS EDEN PHARMACEUTICALS INC /DE/

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

HEPH > SEC Filings for HEPH > Form 8-K on 15-Jun-2009

All Recent SEC Filings

Show all filings for HOLLIS EDEN PHARMACEUTICALS INC /DE/ | Request a Trial to NEW EDGAR Online Pro

Form 8-K for HOLLIS EDEN PHARMACEUTICALS INC /DE/

15-Jun-2009

Change in Directors or Principal Officers, Financial Stateme

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On June 12, 2009, the Board of Directors of Hollis-Eden Pharmaceuticals, Inc. (the "Company") appointed James M. Frincke Ph.D. as President and CEO. Dr. Frincke was also elected to the Company's Board of Directors.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits

99.1 Press release dated June 15, 2009

Add HEPH to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for HEPH - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.